DUPONT DE NEMOURS, INC. (DD) Spending and interest coverage
- R&D / revenue · 12 months: Value 2.56%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.62%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 2.56% | Research and development expense / revenue. Period ending 2026-06-30. $179.00M ÷ $6.99B × 100 ≈ 2.56% |
| Stock-based compensation / revenue · 12 months | 0.62% | Share-based compensation / revenue. Period ending 2026-06-30. $43.00M ÷ $6.99B × 100 ≈ 0.62% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 179.00M USD | Research and Development Expense |
| Revenue | 6.99B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 43.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $179.00M | $6.99B | $43.00M | (m) | (m) | 2.56% | 0.62% | (m) | (m) |
| 2026-03-31 | $190.00M | $6.92B | $44.00M | (m) | (m) | 2.75% | 0.64% | (m) | (m) |
| 2025-12-31 | $193.00M | $6.85B | $38.00M | (m) | (m) | 2.82% | 0.55% | (m) | (m) |
| 2025-09-30 | $565.00M | $12.84B | $60.00M | (m) | (m) | 4.40% | 0.47% | (m) | (m) |
| 2025-06-30 | $551.00M | $12.61B | $64.00M | (m) | (m) | 4.37% | 0.51% | (m) | (m) |
| 2025-03-31 | $543.00M | $12.52B | $66.00M | (m) | (m) | 4.34% | 0.53% | (m) | (m) |
| 2024-12-31 | $531.00M | $12.39B | $77.00M | (m) | (m) | 4.29% | 0.62% | (m) | (m) |
| 2024-09-30 | $521.00M | $12.19B | (m) | (m) | (m) | 4.27% | (m) | (m) | (m) |
| 2024-06-30 | $515.00M | $12.06B | (m) | (m) | (m) | 4.27% | (m) | (m) | (m) |
| 2024-03-31 | $506.00M | $11.98B | (m) | (m) | (m) | 4.22% | (m) | (m) | (m) |
| 2023-12-31 | $508.00M | $12.07B | (m) | (m) | (m) | 4.21% | (m) | (m) | (m) |
| 2023-09-30 | $503.00M | $12.27B | (m) | (m) | (m) | 4.10% | (m) | (m) | (m) |
| 2023-06-30 | $504.00M | $12.53B | (m) | (m) | (m) | 4.02% | (m) | (m) | (m) |
| 2023-03-31 | $520.00M | $12.76B | (m) | (m) | (m) | 4.07% | (m) | (m) | (m) |
| 2022-12-31 | $536.00M | $13.02B | (m) | (m) | (m) | 4.12% | (m) | (m) | (m) |
| 2022-09-30 | $622.00M | $17.25B | (m) | (m) | (m) | 3.61% | (m) | (m) | (m) |
| 2022-06-30 | $630.00M | $17.13B | (m) | (m) | (m) | 3.68% | (m) | (m) | (m) |
| 2022-03-31 | $622.00M | $16.91B | (m) | (m) | (m) | 3.68% | (m) | (m) | (m) |
| 2021-12-31 | $618.00M | $16.65B | (m) | (m) | (m) | 3.71% | (m) | (m) | (m) |
| 2021-09-30 | $615.00M | $16.13B | (m) | (m) | (m) | 3.81% | (m) | (m) | (m) |
| 2021-06-30 | $603.00M | $15.49B | (m) | (m) | (m) | 3.89% | (m) | (m) | (m) |
| 2021-03-31 | $843.00M | $20.70B | (m) | (m) | (m) | 4.07% | (m) | (m) | (m) |
| 2020-12-31 | $860.00M | $20.40B | (m) | (m) | (m) | 4.22% | (m) | (m) | (m) |
| 2020-09-30 | $875.00M | $20.35B | (m) | (m) | (m) | 4.30% | (m) | (m) | (m) |
| 2020-06-30 | $901.00M | $20.68B | (m) | (m) | (m) | 4.36% | (m) | (m) | (m) |
| 2020-03-31 | $924.00M | $21.32B | (m) | (m) | (m) | 4.33% | (m) | (m) | (m) |
| 2019-12-31 | $955.00M | $21.51B | (m) | (m) | (m) | 4.44% | (m) | (m) | (m) |
| 2019-09-30 | $2.98B | $85.15B | (m) | (m) | (m) | 3.50% | (m) | (m) | (m) |
| 2019-06-30 | $3.02B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $3.01B | $84.12B | (m) | (m) | (m) | 3.58% | (m) | (m) | (m) |
| 2018-12-31 | $3.06B | $85.98B | (m) | (m) | (m) | 3.56% | (m) | (m) | (m) |
| 2018-09-30 | $3.07B | $85.94B | (m) | (m) | (m) | 3.57% | (m) | (m) | (m) |
| 2018-06-30 | $2.85B | $81.17B | (m) | (m) | (m) | 3.52% | (m) | (m) | (m) |
| 2018-03-31 | $2.46B | $70.76B | (m) | (m) | (m) | 3.47% | (m) | (m) | (m) |
| 2017-12-31 | $2.11B | $62.48B | (m) | (m) | (m) | 3.38% | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $52.57B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $50.69B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $1.58B | $48.16B | (m) | (m) | (m) | 3.29% | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $1.60B | $48.78B | (m) | (m) | (m) | 3.28% | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DOW INC. (DOW) | United States | $20.577B | -11.55 |
| ALBEMARLE CORP (ALB) | United States | $12.778B | 71.05 |
| EASTMAN CHEMICAL CO (EMN) | United States | $7.575B | 17.34 |
| HEXCEL CORP /DE/ (HXL) | United States | $6.464B | 49.18 |
| AVIENT CORP (AVNT) | United States | $3.739B | 19.95 |
| ROGERS CORP (ROG) | United States | $2.435B | -34.15 |
| PureCycle Technologies, Inc. (PCT) | United States | $0.975B | -7.32 |
| AdvanSix Inc. (ASIX) | United States | $0.426B | -30.25 |